Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
...monstrated for the first time in a large study population that delivery of cyanocobalamin via sublingual lozenges resulted in significant increases in cobalamin blood levels. Cobalis' Chief Scientific Officer Ernest Armstrong commented: "Showing a meaningful reduction in allergy symptoms when the symptoms ne...Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
...ons. Mr. Seiler has also resigned from the Board of Directors. "I believe that Access has an exciting future with ProLindac(TM), MuGard(TM), and the cobalamin Vitamin B-12 oral delivery technology. The Company is positioned well for 2008 to be an eventful year. Access has been a rewarding experience and I am...